Literature DB >> 12584331

The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.

Laurie J Earp1, Sue E Delos, Robert C Netter, Paul Bates, Judith M White.   

Abstract

We previously showed that the envelope glycoprotein (EnvA) of avian sarcoma/leukosis virus subtype A (ASLV-A) binds to liposomes at neutral pH following incubation with its receptor, Tva, at >or=22 degrees C. We also provided evidence that ASLV-C fuses with cells at neutral pH. These findings suggested that receptor binding at neutral pH and >or=22 degrees C is sufficient to activate Env for fusion. A recent study suggested that two steps are necessary to activate avian retroviral Envs: receptor binding at neutral pH, followed by exposure to low pH (W. Mothes et al., Cell 103:679-689, 2000). Therefore, we evaluated the requirements for intact ASLV-A particles to bind to target bilayers and fuse with cells. We found that ASLV-A particles bind stably to liposomes in a receptor- and temperature-dependent manner at neutral pH. Using ASLV-A particles biosynthetically labeled with pyrene, we found that ASLV-A mixes its lipid envelope with cells within 5 to 10 min at 37 degrees C. Lipid mixing was neither inhibited nor enhanced by incubation at low pH. Lipid mixing of ASLV-A was inhibited by a peptide designed to prevent six-helix bundle formation in EnvA; the same peptide inhibits virus infection and EnvA-mediated cell-cell fusion (at both neutral and low pHs). Bafilomycin and dominant-negative dynamin inhibited lipid mixing of Sindbis virus (which requires low pH for fusion), but not of ASLV-A, with host cells. Finally, we found that, although EnvA-induced cell-cell fusion is enhanced at low pH, a mutant EnvA that is severely compromised in its ability to support infection still induced massive syncytia at low pH. Our results indicate that receptor binding at neutral pH is sufficient to activate EnvA, such that ASLV-A particles bind hydrophobically to and merge their membranes with target cells. Possible roles for low pH at subsequent stages of viral entry are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584331      PMCID: PMC149735          DOI: 10.1128/jvi.77.5.3058-3066.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation.

Authors:  R G Paterson; C J Russell; R A Lamb
Journal:  Virology       Date:  2000-04-25       Impact factor: 3.616

2.  Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Authors:  S Watanabe; A Takada; T Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Permeation and activation of the M2 ion channel of influenza A virus.

Authors:  J A Mould; J E Drury; S M Frings; U B Kaupp; A Pekosz; R A Lamb; L H Pinto
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

4.  The solution structure of the viral binding domain of Tva, the cellular receptor for subgroup A avian leukosis and sarcoma virus.

Authors:  M Tonelli; R J Peters; T L James; D A Agard
Journal:  FEBS Lett       Date:  2001-12-07       Impact factor: 4.124

Review 5.  The machinery for flavivirus fusion with host cell membranes.

Authors:  F X Heinz; S L Allison
Journal:  Curr Opin Microbiol       Date:  2001-08       Impact factor: 7.934

6.  The central proline of an internal viral fusion peptide serves two important roles.

Authors:  S E Delos; J M Gilbert; J M White
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.

Authors:  S A Gallo; A Puri; R Blumenthal
Journal:  Biochemistry       Date:  2001-10-16       Impact factor: 3.162

8.  Temperature dependence of fusion by sendai virus.

Authors:  S A Wharton; J J Skehel; D C Wiley
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

9.  Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.

Authors:  I Muñoz-Barroso; S Durell; K Sakaguchi; E Appella; R Blumenthal
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

10.  Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.

Authors:  S E Delos; J M White
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

View more
  41 in total

1.  The interaction of alphavirus E1 protein with exogenous domain III defines stages in virus-membrane fusion.

Authors:  Gleyder Roman-Sosa; Margaret Kielian
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content-mixing assay.

Authors:  Andrey A Kolokoltsov; Robert A Davey
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

3.  Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.

Authors:  Shutoku Matsuyama; Sue Ellen Delos; Judith M White
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Liposome reconstitution of a minimal protein-mediated membrane fusion machine.

Authors:  Deniz Top; Roberto de Antueno; Jayme Salsman; Jennifer Corcoran; Jamie Mader; David Hoskin; Ahmed Touhami; Manfred H Jericho; Roy Duncan
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

5.  Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEM.

Authors:  J Charles Whitbeck; Yi Zuo; Richard S B Milne; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Antibody binding in proximity to the receptor/glycoprotein complex leads to a basal level of virus neutralization.

Authors:  Xinzhen Yang; Inna Lipchina; Michelle Lifton; Liping Wang; Joseph Sodroski
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

7.  Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.

Authors:  Makoto Ujike; Hiroki Nishikawa; Akira Otaka; Naoki Yamamoto; Norio Yamamoto; Masao Matsuoka; Eiichi Kodama; Nobutaka Fujii; Fumihiro Taguchi
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

8.  Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion.

Authors:  Doina Atanasiu; J Charles Whitbeck; Tina M Cairns; Brigid Reilly; Gary H Cohen; Roselyn J Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

Review 9.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

10.  A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle.

Authors:  R M Markosyan; P Bates; F S Cohen; G B Melikyan
Journal:  Biophys J       Date:  2004-08-31       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.